Home > Income Statement > NATCO PHARMA

NATCO PHARMA
Appropriations

    Back to Income Statement
NATCO PHARMA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for NATCO PHARMA
Please provide your vote to see the results

NATCO PHARMA Last 5 Year Appropriations History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Appropriations ₹6,351 Cr₹4,681 Cr₹3,382 Cr₹2,738 Cr₹2,680 Cr

What is the latest Appropriations of NATCO PHARMA ?

The latest Appropriations ratio of NATCO PHARMA is ₹6,351 Cr based on Mar2025 Consolidated results.
Year Appropriations
Mar2025₹6,351 Cr
Mar2024₹4,681 Cr
Mar2023₹3,382 Cr
Mar2022₹2,738 Cr
Mar2021₹2,680 Cr

How is Appropriations of NATCO PHARMA Trending?

Years Appropriations % Change
Mar2025 ₹6,351 Cr
35.69
Mar2024 ₹4,681 Cr
38.40
Mar2023 ₹3,382 Cr
23.51
Mar2022 ₹2,738 Cr
2.17
Mar2021 ₹2,680 Cr -

Compare Appropriations of peers of NATCO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATCO PHARMA ₹16,456.6 Cr -2.8% 2.9% -8.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹468,842.0 Cr 1.1% 4.6% 14.2% Stock Analytics
DIVIS LABORATORIES ₹193,860.0 Cr 0.6% 8.3% 8.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹192,687.0 Cr 6.3% 12.2% 45.5% Stock Analytics
CIPLA ₹112,593.0 Cr -1.7% -2.8% -4% Stock Analytics
DR REDDYS LABORATORIES ₹97,364.9 Cr -3.7% -10.4% -6% Stock Analytics


NATCO PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
NATCO PHARMA

-2.8%

2.9%

-8.4%

SENSEX

-1%

-0.9%

-7.5%


You may also like the below Video Courses